ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,907
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
A phase 1b/2 study of selinexor, carfilzomib, and dexamethasone (SKd) in relapsed/refractory multiple myeloma (RRMM). Abstract PS1414
Author(s):
C. Gasparetto
,
S Lentzsch
,
G SCHILLER
,
N. Callander
,
C. CHEN
,
D. WHITE
Publication date:
2019
Read this book at
Bookmark
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
NTT Journal for Theology and the Study of Religion
Data availability:
Comments
Comment on this book
Sign in to comment
Similar content
3,907
SKD enhances Rovatti centrifugal range
Authors:
FATIGUE CHARACTERISTICS OF SKD-61 BY ULTRASONIC NANOCRYSTAL SURFACE MODIFICATION TECHNOLOGY UNDER STATIC LOAD VARIATION
Authors:
CHANG-MIN SUH
,
MOON-HWAN LEE
,
YOUNG-SIK PYOUN
XpovioTM (selinexor) tablets [prescribing onformation]
Authors:
USPI Xpovio
See all similar
Cited by
1
Overall survival with oral selinexor plus low‐dose dexamethasone versus real‐world therapy in triple‐class‐refractory multiple myeloma
Authors:
Paul Richardson
,
Sundar Jagannath
,
Ajai Chari
…
See all cited by